Business Context and Reporting Period
This Form 6-K filing by Compugen Ltd. (NASDAQ: CGEN) is dated January 23, 2014, covering the month of January 2014. The Company is a foreign private issuer based in Tel-Aviv, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
The primary material change reported is the approval by the Nasdaq Listing Qualifications Department to transfer Compugen's ordinary shares from The NASDAQ Capital Market to The NASDAQ Global Market. This transfer is scheduled to take effect at the opening of business on January 27, 2014. The trading symbol "CGEN" will remain unchanged.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely to announce the listing upgrade and incorporates the information by reference into the Company's Registration Statements on Form F-3 and 333-185910.
Investor Verification Checklist
- Confirm the effective date of the listing transfer to The NASDAQ Global Market (January 27, 2014).
- Verify that the trading symbol remains "CGEN" post-transfer.
- Review the referenced Registration Statements (Form F-3 and 333-185910) for detailed financial data not included in this summary.